A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis
Status:
Completed
Trial end date:
2018-08-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether VIB4920 (formerly MEDI4920) is safe and
well tolerated in participants with adult-onset rheumatoid arthritis (RA).